batu

BATU is a Viricide.

Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate (ADC) that targets cancer cells expressing transmembrane glycoprotein NMB (GPNMB). Glembatumumab vedotin has potent anticancer effects and can be used in the study of triple negative breast cancer (TNBC).

Robatumumab (Sch 717454) is a fully human anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody with antitumor and antiproliferative activity.Robatumumab is used in the study of ovarian cancer.

Glembatumumab is a fully human IgG2 monoclonal antibody targeting the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. It is a naked antibody to Glembatumumab vedotin and can be used to study antibody-activated molecule couplings (Glembatumumab vedotin).

Glembatumumab, CY3 labeled is a humanized antibody targeting the extracellular domain of GPNMB, with potential antitumor activity, used in studies of triple-negative breast cancer.

Calpurbatug is an immunoglobulin G1 (IgG1) antibody that exhibits affinity for the anti-bacterial DNA-binding protein DNABII family as well as the anti-human monoclonal TRL1068 γ1-chain [1].